Stockscreener 앱 받기
0.00
100.00%
-0.03
시간 외 거래:
.03
0.03
+
Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스
Iterum Therapeutics plc Revenue Breakdown – OTC:ITRMF - TradingView
Price to earnings forward of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Iterum Therapeutics (ITRM) Q2 2025 earnings summary - Quartr
Iterum Therapeutics plc Actuals & Estimates (OTC:ITRMF) - TradingView
ITRMF Forecast — Price Target — Prediction for 2027 - TradingView
Iterum Therapeutics PLC (ITRM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ITRMF Stock Price, News & Analysis - Stock Titan
ITRMF SEC FilingsIterum Therapeutics Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Iterum Therapeutics (ITRMF) files Form 25 to remove Ordinary Shares from Nasdaq - Stock Titan
Iterum Therapeutics (ITRM) Proxy Filing Summary - Quartr
Iterum Therapeutics PLC (ITRM) Institutional Confidence - TradingKey
Iterum Therapeutics PLC (ITRM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Iterum Therapeutics PLC (ITRM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Iterum Therapeutics PLC (ITRM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Iterum Therapeutics PLC (ITRM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Iterum Therapeutics PLC (ITRM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Iterum Therapeutics (ITRM) Holds at $0.03 as Micro-Cap Biotech Waits for CatalystsNew Listing Stocks - The Legal Advocate
Iterum Therapeutics (ITRM) Holds at $0.03 as Trading Volume Remains SubduedLow Risk Entry Stocks - dars.gov.et
Iterum (ITRM) Stalls at $$0.03 — Consolidation Phase 2026-05-15Social Sentiment - The Legal Advocate
Iterum Therapeutics PLC (ITRMF) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Iterum Therapeutics PLC (ITRMF) DCF Valuation - GuruFocus
Iterum Therapeutics PLC (ITRMF) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock Earnings Transcripts - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Competitors 2026 - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Dividend - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock Price & 30 Year Financial Data - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Valuation - GuruFocus
Iterum Therapeutics PLC Stock Operating Data - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
Who's Buying or Selling Iterum Therapeutics PLC (OTCM:ITRMF) Stock Today? - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock News, Headlines & Updates - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) SEC filings - GuruFocus
ITERUM THERAPEUTICS PLC (ITRM) SHAREHOLDER CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Iterum Therapeutics plc - TMX Newsfile
Iterum Therapeutics PLC (ITRMF) - MSN
Iterum Therapeutics plc Financial Disclosures & SEC Filings - TradingView
Iterum Therapeutics (ITRM) Q3 2024 earnings summary - Quartr
Iterum Therapeutics (ITRM) Investor Presentation Summary - Quartr
Iterum Therapeutics (ITRM) FDA Announcement Summary - Quartr
Top pre-market gainers today — ELAB, ITRM, LTRN among stocks soaring before the bell - MSN
Iterum Therapeutics PLC (ITRMF) SEC filings - GuruFocus
ITRMF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Iterum Therapeutics plc (ITRMF) Competitors - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Down Today? - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Up Today? - Meyka
Iterum (ITRM) Stock Collar Strategy (Trend Strengthens) 2026-04-18Risk Analysis - Xã Thanh Hà
A 25-year pharma finance veteran takes over as Eton CFO on June 1 - Stock Titan
What's going on with Iterum Therapeutics stock Monday? - MSN
Retail Surge: Does Iterum Therapeutics plc outperform in volatile markets2026 Momentum & Comprehensive Market Scan Reports - baoquankhu1.vn
Dividend HistoryIterum Therapeutics (ITRMF) - Zacks Investment Research
Published on: 2026-04-10 21:42:25 - baoquankhu1.vn
Breakout Zone: What are the future prospects of Iterum Therapeutics plc2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
ITRMF (Iterum Therapeutics) Dividend Payout Ratio : 0.00 (As of Sep. 2025) - GuruFocus
Iterum Therapeutics plc (ITRMF) stock price, news, quote and history - Yahoo Finance Australia
Iterum Therapeutics plc (ITRMF) Dividend News Alerts - DividendInvestor.com
Iterum Therapeutics plc (ITRMF) insider ownership and holdings - Yahoo Finance Singapore
Iterum Therapeutics plc (ITRMF) Latest Stock News & Headlines - Yahoo! Finance Canada
ITRMF (Iterum Therapeutics) Marketable Securities : $0.00 Mil (As of Sep. 2025) - GuruFocus
Iterum Therapeutics plc (ITRMF) Stock Price, News, Quote & History - Yahoo! Finance Canada
EBITDA of Iterum Therapeutics plc – OTC:ITRMF - TradingView
0.40%
0.43%
자본화:
|
볼륨(24시간):